Pharmacologic Treatment Options for Type 1 Diabetes: What’s New?

INTRODUCTION: The expanding variety of insulins, including biosynthetic human insulin and rapid and long-acting insulin analogs, have dramatically transformed the management of type 1 diabetes (T1D) over the past 25 years. Moreover, increasing interest in the use of novel drugs developed for the tre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert Rev Clin Pharmacol
Hlavní autoři: Nally, Laura M., Sherr, Jennifer L., Van Name, Michelle A., Patel, Anisha D., Tamborlane, William V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488361/
https://ncbi.nlm.nih.gov/pubmed/30892094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2019.1597705
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky